Publications by authors named "Rob Jones"

Claim this Profile
U
UK real-world data of radium-223 dichloride in metastatic prostate cancer.
Manreet Randhawa, Gail Buchanan, Irene M Stratton, Gemma Race, Amar Challapalli, Rob J Jones

Nucl Med Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer.
Jeff C Liu, Letizia Granieri, Mariusz Shrestha, Dong-Yu Wang, Ioulia Vorobieva, Rob Jones

Cell Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma.
Claire Glen, Stephen J H Dobbin, Kenneth Mangion, Alasdair Henderson, Katriona Brooksbank, Rob Jones

JACC CardioOncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK Kidney Association Clinical Practice Guideline on vascular access for haemodialysis.
Emma Aitken, Hameed Anijeet, Damien Ashby, Wayne Barrow, Francis Calder, Rob Jones

BMC Nephrol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capivasertib/Fulvestrant in patients with HR+, HER2-low or HER2-negative locally advanced or metastatic breast cancer.
Karam Aboud, Magda Meissner, Rob Jones

Ther Adv Med Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of therapy quality on outcomes from behavioural activation and guided self-help treatments for depression in adults with intellectual disabilities.
Dave Dagnan, Paul Thompson, Richard P Hastings, Chris Hatton, Chris Melville, Rob S P Jones

Br J Clin Psychol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of cancer in people with CKD not requiring kidney replacement therapy: a systematic review and meta-analysis.
Benjamin M P Elyan, Beatrix Tan, Emilie Lambourg, David A McAllister, Rob J Jones

Clin Kidney J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assurance in surgical trials of arteriovenous grafts for haemodialysis: A systematic review, a narrative exploration and expert recommendations.
David B Kingsmore, Ben Edgar, Emma Aitken, Francis Calder, Marco Franchin, Rob G Jones

J Vasc Access· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time: a single centre retrospective analysis.
Benjamin M P Elyan, Michael K Sullivan, James Hedley, Nicole De La Mata, Angela C Webster, Rob J Jones

BJC Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment into randomised trials of arteriovenous grafts: A systematic review.
David Kingsmore, Richard D White, Gaspar Mestres, Mike Stephens, Francis Calder, Rob G Jones

J Vasc Access· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis.
Teifion Luckett, Maidinaimu Abudula, Lucy Ireland, Mark Glenn, Gaia Bellomo, Rob Jones

Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, treatment, and survival from kidney cancer: real-world National Health Service England data between 2013 and 2019.
Samantha Conroy, James W F Catto, Axel Bex, Janet E Brown, Jon Cartledge, Rob J Jones

BJU Int· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of Shredded Aluminium Scrap Metal Using Magnetic Induction Spectroscopy.
Kane C Williams, Michael J Mallaburn, Martin Gagola, Michael D O'Toole, Rob Jones

Sensors (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assurance in surgical trials of arteriovenous grafts for haemodialysis: protocol for a systematic review.
Ben Edgar, David B Kingsmore, Emma Aitken, Francis Calder, Marco Franchin, Rob G Jones

BMJ Open· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review.
Benjamin M P Elyan, Stephen Rankin, Rob Jones, Ninian N Lang, Patrick B Mark

Kidney Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real-world findings from NHS England between 2013 and 2019.
James W F Catto, Olena Mandrik, Lewis A Quayle, Syed A Hussain, John McGrath, Rob J Jones

BJU Int· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.
Silke Gillessen, Alberto Bossi, Ian D Davis, Johann de Bono, Karim Fizazi, Rob Jones

Eur J Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II proof-of-concept study of atorvastatin in castration-resistant prostate cancer.
Linda K Rushworth, Carolyn Loveridge, Mark Salji, Martin MacLeod, Ernest Mui, Rob Jones

BJU Int· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial.
Paul Gravestock, Emma Clark, Miranda Morton, Shirya Sharma, Holly Fisher, Rob Jones

NIHR Open Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Nicholas D James, Noel W Clarke, Adrian Cook, Adnan Ali, Alex P Hoyle, Rob J Jones

Int J Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021.
Fabio Turco, Andrew Armstrong, Gerhardt Attard, Tomasz M Beer, Himisha Beltran, Rob Jones

Eur Urol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "What Experts Think About Prostate Cancer Management During the COVID-19 Pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021" [Eur Urol 82(1):6-11].
Fabio Turco, Andrew Armstrong, Gerhardt Attard, Tomasz M Beer, Himisha Beltran, Rob Jones

Eur Urol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data.
Caroline S Clarke, Rachael M Hunter, Andrea Gabrio, Christopher D Brawley, Fiona C Ingleby, Rob J Jones

PLoS One· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
Chris C Parker, Nicholas D James, Christopher D Brawley, Noel W Clarke, Adnan Ali, Rob J Jones

PLoS Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer.
Emma Dunlop, Aimee Ferguson, Tanja Mueller, Kelly Baillie, Julie Clarke, Rob Jones

Support Care Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis